other species- specific resistance mechanisms have been characterized including enzymatic oxidative decomposition of the drug inscheme 10. myers' 2008 extension of the dts approach to expand on leads identified in 2005 workscheme 11. nicolaou's construction of the viridicatumtoxin skeletonbacteroides via tetx which has not been observed in any other bacteria.a previously poorly understood tetu was thought to exhibit rpp-like activity based on reported low-level resistance and some sequence similarity with tetm but expression of tetu alone in e. coli conferred no resistance to several common tetracyclines tested.given that tetracyclines are intended as broad-spectrum agents these singular instances of resistance are not of major concern to drug discovery efforts.semisynthetic approaches to tetracyclinesgiven the rapid evolution of two mechanisms of resistance to tetracycline the budding pharmaceutical industry fought to keep ahead of these pathogens by developing new tetracyclines that could overcome this resistance.

hunt d. k. he m. achorn c. chen c. l. deng y. fyfe c. grossman t. h. hogan p. c. o'brien w. j. clark r. b.et al.

2017 56 3940-3944.pettersen e. f. goddard t. d. huang c. c. couch g. s. greenblatt d. m. meng e. c. ferrin t. e. ucsf chimera-a visualization system for exploratory research and analysis.

2017 21 377-386.sun c. wang q. brubaker j. d. wright p. m. lerner c. d. noson k. charest m. siegel d. r. wang y. myers a. g. a robust platform for the synthesis of new tetracycline antibiotics.

2008 130 17913-17927.sun c. hunt d. k. chen c. l. deng y. he m. clark r. b. fyfe c. grossman t. h. sutcliffe j. a. xiao x. y. design synthesis and biological evaluation of hexacyclic tetracyclines as potent broad spectrum antibacterial agents.

2012 55 597.clark r. b. hunt d. k. he m. achorn c. chen c.-l. deng y. fyfe c. grossman t. h. hogan p. c. o'brien w. j. et al.

2015 15 235-242.walsh c. antibiotics actions origins resistance asm presswashington dc 2003.walsh c. t. wencewicz t. a. antibiotics challenges mechanisms opportunities asm press washington dc 2016.bourne c. r. utility of the biosynthetic folate pathway for targets in antimicrobial discovery.

2011 2 68-72.wagh b. paul t. glassford i. debrosse c. klepacki d. small m. c. mackerell a. d. andrade r. b. desmethyl macrolides synthesis and evaluation of 48-didesmethyl telithromycin.

2012 3 1013-1018.glassford i. lee m. wagh b. velvadapu v. paul t. sandelin g. debrosse c. klepacki d. small m. c. mackerell a. d. et al.

2015 137 3693-3704.losey h. c. jiang j. biggins j. b. oberthur m. ye x. y.dong s. d. kahne d. thorson j. s. walsh c. t. incorporation of glucose analogs by gtfe and gtfd from the vancomycin biosynthetic pathway to generate variant glycopeptides.

cell 2014 158 705-721.hill c. jain a. takemoto h. silver m. d. nagesh s. v. s. ionita c. n. bednarek d. r. rudin s. antibiotics in early life and obesity.

2017 19 2366-2369.huigens r. w. iii ma l. gambino c. moeller p. d. r. basso a. cavanagh j. wozniak d. j. melander c. control of bacterial biofilms with marine alkaloid derivatives.

2000 29 646-647.charest m. g. lerner c. d. brubaker j. d. siegel d. r. myers a. g. a convergent enantioselective route to structurally diverse 6-deoxytetracycline antibiotics.

2008 52 2647- 2652.stryjewski m. e. graham d. r. wilson s. e. o'riordan w.young d. lentnek a. ross d. p. fowler v. g. hopkins a. friedland h. d. et al.

antibiotic resistance threats in the united states 2013.white d. g. zhao s. sudler r. ayers s. friedman s. chen s. mcdermott p. f. mcdermott s. wagner d. d. meng j. the isolation of antibiotic-resistant salmonella from retail ground meats.

